O'Shaughnessy Asset Management, LLC Immuno Gen, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.26 - $7.48 $53,761 - $94,397	-12,620 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.75 - $7.5 $24,296 - $38,362	5,115 Added 68.15%	12,620 $94,000
Q3 2021 Nov 10, 2021	SELL	$5.02 - $6.59 $42,905 - $56,324	-8,547 Reduced 53.25%	7,505 $43,000
Q2 2021 Aug 09, 2021	BUY	$5.79 - $8.6 $10,960 - $16,279	1,893 Added 13.37%	16,052 $106,000
Q1 2021 May 14, 2021	SELL	$6.5 - $10.53 $135,577 - $219,634	-20,858 Reduced 59.57%	14,159 $115,000
Q4 2020 Feb 11, 2021	BUY	$3.7 - $7.66 $124,974 - $258,731	33,777 Added 2723.95%	35,017 $226,000
Q2 2020 Aug 13, 2020	BUY	$3.32 - $5.34 $4,116 - $6,621	1,240 New	1,240 $6,000
Q1 2020 May 13, 2020	SELL	$2.12 - $6.8 $4,059 - $13,022	-1,915 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$2.25 - $5.8 $4,308 - $11,107	1,915 New	1,915 $10,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.